Recombinant protein production system comprising multiple culture trains, multiple harvest trains, and multiple purification trains, and method for producing recombinant protein using same
The recombinant protein production system with multiple trains addresses efficiency and flexibility issues in biopharmaceutical manufacturing by allowing simultaneous and independent operation of culture, recovery, and purification trains, enhancing productivity and reducing facility costs.
Patent Information
- Application Number
- PCT/KR2026/096868
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-12
- Filing Date
- 2026-05-12
- Publication Date
- 2026-11-19
AI Technical Summary
Conventional biopharmaceutical manufacturing plants face limitations in scale and productivity relative to investment, with single purification trains reducing annual operating time due to purification unit downtime and product change-over (PCO) requirements, especially when producing high-titer culture products or multiple antibodies, leading to decreased facility efficiency and increased production costs.
A recombinant protein production system comprising multiple culture trains, recovery trains, and purification trains, with each train being atmospherically separated and mechanically segregated, allowing independent and simultaneous operation, and utilizing dedicated buffer storage vessels to enhance flexibility and efficiency.
The system significantly increases productivity and flexibility by enabling simultaneous processing of multiple batches without cross-contamination, reducing PCO time, and optimizing resource use, thereby doubling batch production speed and minimizing facility investments.
Smart Images

Figure KR2026096868_19112026_PF_FP_ABST
Abstract
Description
A recombinant protein production system comprising multiple culture trains, multiple recovery trains, and multiple purification trains, and a method for producing recombinant proteins using the same
[0001] The present invention relates to a recombinant protein production system comprising multiple culture trains, multiple recovery trains, and multiple purification trains, and a method for producing recombinant proteins using the same.
[0002]
[0003] The manufacture of biological materials intended for use as pharmaceuticals must be carried out in facilities that meet licensing standards, such as Good Manufacturing Practice (GMP). In particular, after biological materials are produced through microbial or cell culture, a purification system is essential to enhance the purity of the target substance and remove contaminants such as viruses.
[0004] Currently, conventional biopharmaceutical manufacturing plants face limitations in increasing scale and productivity relative to investment, resulting in low efficiency relative to investment. Therefore, it is common practice to configure one purification train within one culture train (multiple bioreactors) for production.
[0005] The present invention relates to a method for designing and operating a multi-refining train plant that can maximize product productivity and dramatically increase the flexibility of production for each product.
[0006] For the Product Change-Over (PCO) of existing purification equipment, a method is used in which all various purification units, such as chromatography units, filtration (UF / DF) units, and bulk fill units included in each purification equipment, are replaced, cleaned, and / or sterilized after all purification processes are completed. In this case, even though the purification units in the front part of the purification equipment have already completed their purification roles, they cannot be operated until purification in the subsequent purification units is completed to prevent cross-contamination, and PCO for the production of the next product is performed after all purification processes are completed.
[0007] In this case, both the time the purification unit is not in use and the time required for PCO become factors that reduce the plant's annual operating time. This is generally considered an inevitable time requirement in conventional biopharmaceutical production facilities, and to mitigate this, the industry is conducting research on various methods to reduce the PCO time itself, primarily by shortening the replacement time of the purification unit.
[0008]
[0009] Purification trains typically account for about half of the total plant investment, representing a significant portion of the overall facility investment.
[0010] In existing recombinant protein culture / purification processes, there are technical and design limitations in achieving high productivity of a single purification train relative to investment, so typically only one purification train is applied to a single culture train. In particular, there have been no reported cases of multiple purification trains being applied or operated to a single culture train in large commercial production facilities with a capacity of 10,000 L or more based on this bioreactor.
[0011] The annual productivity (number of batches) of the plant is determined by the purification / production speed of a single train. In addition, if the purification process requires a long purification time, or if process complexity is required, such as the conjugation of multiple antibodies, the annual productivity of the plant drops sharply compared to the general case.
[0012]
[0013] The design of a recombinant protein production plant typically involves one purification train and consists of one production train (culture train is also used in the same sense) composed of a limited number (e.g., 1 to 6) of main culture bioreactors.
[0014] This is because the maximum productivity (number of batches / specific period) of existing recombinant protein production plants is dependent on the maximum production speed of a single purification train and cannot increase in direct proportion to the number of culture incubators.
[0015] In particular, prior to the development of the novel process design according to the present invention, there were no reported cases in which multiple purification trains were actually applied and operated in a single culture train (e.g., ≥10 main culture bioreactors) in a large commercial production facility with a culture capacity of 10,000 L or more.
[0016] In addition, due to advancements in biological drug technology and changes in technological trends, there is an increase in the production of high-titer (high titer g / L) culture products and the variety of drugs conjugated with multiple antibodies. However, when producing high-titer culture products in large-scale production (over 10,000L) using existing factory designs, problems arise regarding exceeding processing capacity in the purification stage. Furthermore, the complexity of the purification process in the production of multiple antibodies inevitably leads to a decline in annual productivity relative to the facility's design. Moreover, an additional freezing process is required to sequentially process the produced culture media within a single purification facility. This, along with the need for additional freezing and long-term storage equipment, reduces the facility's annual production capacity and makes continuous batch production impossible. Consequently, in some cases, this can delay the timely supply of the aforementioned drugs to patients and increase the manufacturing cost.
[0017]
[0018] In particular, due to the problems with these existing processes, there are the following unmet needs in terms of market and technical aspects regarding the production of high-concentration culture products such as antibodies and proteins, as well as multiple antibodies.
[0019] (a) With the advancement of biological drug technology, there is an increasing number of products using strains capable of producing high concentrations (High Titer). This often exceeds the processing capacity in the purification process with the existing industry's established equipment design of one culture train: one purification train. Consequently, the factory's originally designed capacity cannot be fully utilized (requiring production with reduced culture volume), or production may become impossible in the facility due to a decrease in factory productivity resulting from increased purification time, or in some cases, production must be carried out below the minimum operating range of the existing production line.
[0020] (b) For drugs requiring antibody conjugation during the purification process, such as multiple antibodies, the maximum productivity of a plant is limited not only by the long purification process but also by the requirement to produce N antibodies, purify them, and then re-purify and conjugate them, which necessitates N product changeover periods. This is a factor that causes the productivity of the plant to drop significantly compared to the general case.
[0021]
[0022] Therefore, there is an urgent need for new biological drug production and purification systems that address unmet needs in terms of market and technology.
[0023]
[0024] The present invention aims to provide a new system with enhanced recombinant protein productivity and product production flexibility, characterized by using multiple culture trains, multiple recovery trains, and multiple purification trains to solve the aforementioned existing problems.
[0025]
[0026] To solve the above problem, the present invention provides a production system comprising a plurality of culture trains including at least one bioreactor for producing a recombinant protein, a plurality of recovery trains including at least one recovery unit for recovering the produced recombinant protein from the bioreactor, and a plurality of purification trains for purifying the recovered recombinant protein (see FIGS. 1 to 4).
[0027] In one embodiment of the present invention, each of the culture train, recovery train, and purification train is connected to each other through a manifold including a multi-organic pipe, and the purification train includes at least one purification unit, and each purification train may be atmospherically separated from each other, but is not limited thereto.
[0028] In the present invention, the term “cultivation train” refers to a zone that performs the function of culturing production cells to produce antibodies and recombinant proteins, etc., and is used to mean a single system comprising unit units for cultivation, such as a bioreactor for culturing production cells and a medium supply device.
[0029] In the present invention, the term “Harvest train” is used to mean a single system comprising a section that performs the function of recovering a culture medium containing recombinant proteins produced from a culture train, and includes one or more harvest units selected from the group consisting of centrifuges and depth filters, and a unit for recovery such as a cell culture harvest solution vessel (HCCF Vessel; Harvest Cell Culture Fluid Vessel).
[0030] In the present invention, the term “purification train” refers to a zone that performs the function of purifying produced antibodies and recombinant proteins, etc., and is used to mean a single system including unit units for purification such as chromatography and filtration devices.
[0031] The above multiple culture trains may include 1 to 10, preferably 1 to 6, and more preferably 1 to 4 culture trains, but are not limited thereto.
[0032] In addition, the above multiple tablet trains may include 2 to 10, preferably 2 to 5, and more preferably 2 to 4 tablet trains, but are not limited thereto.
[0033] The above multiple recovery trains may include 2 to 10, preferably 2 to 6, recovery trains, and preferably have the same number as the number of purification trains, but are not limited thereto.
[0034] For example, if a recombinant protein production system according to one embodiment of the present invention includes a total of three culture trains, each culture train may be independently named as a first culture train, a second culture train, a third culture train, etc., but is not limited thereto.
[0035] In addition, for example, if a recombinant protein production system according to one embodiment of the present invention includes a total of three recovery trains, each recovery train may be independently named as a first recovery train, a second recovery train, a third recovery train, etc., but is not limited thereto.
[0036] In addition, for example, if a recombinant protein production system according to one embodiment of the present invention includes a total of three purification trains, each purification train may be independently named as a first purification train, a second purification train, a third purification train, etc., but is not limited thereto.
[0037] In addition, the bioreactors included in the above culture train may include 1 to 10, preferably 1 to 6, or 2 to 6 in other respects per culture train, and more preferably 1 or 2, but are not limited thereto.
[0038] In addition, one recovery train may each independently contain two or more cell culture harvest solution containers (see Figure 4).
[0039] The cell culture harvesting solution vessel (HCCF Vessel) is an intermediate vessel used to lower the temperature or stir at the final stage of recovery and to prepare for the first purification process; typically, one cell culture harvesting solution vessel is used per recovery train. However, to support effects such as increased speed through multiple purification trains, separation of high-concentration culture medium (into 2 batches), and separation of batches for the multi-antibody process (into 2 batches), redundancy of the cell culture harvesting solution vessel (HCCF Vessel) is required. This configuration enables more efficient production of recombinant proteins and, in particular, allows for process flexibility depending on the product (type).
[0040]
[0041] A production system for recombinant proteins according to one embodiment of the present invention is characterized by including two or more purification trains per culture train and satisfying one or more technical features selected from (a) to (g) below.
[0042] (a) Each refinery train can be operated independently, selectively, and simultaneously.
[0043] (b) Each refinery train has airflow that is atmospherically segregated from one another.
[0044] (c) Fluid flow including product and buffer is mechanically segregated
[0045] (d) Buffer solutions used in the purification process depend on individual buffer hold vessels for each type (1 vs 1 matching)
[0046] (e) A product / buffer transfer line is configured to purify two or more batches of the same product simultaneously without cross-contamination.
[0047] (f) A product / buffer transfer line is configured to produce two or more types of products simultaneously without cross-contamination.
[0048] (g) Equipment including columns and skids is moved between refining trains to form a usable production cleanroom.
[0049] (h) Enhanced product operational flexibility through the application of a line manifold capable of lateral transfer and a dual HCCF vessel design (enabling simultaneous batch production and batch splitting operation)
[0050]
[0051] Preferably, the recombinant protein production system according to the present invention is,
[0052] A multiple culture train comprising at least one bioreactor for producing recombinant proteins;
[0053] A plurality of recovery trains comprising at least one recovery unit for recovering the produced recombinant protein from the bioreactor; and
[0054] It comprises multiple purification trains, each including at least one purification unit for purifying the recombinant protein produced above, and
[0055] The multiple culture trains and the multiple recovery trains may be connected through a first manifold, and the multiple recovery trains and the multiple purification trains may be connected through a second manifold (see FIGS. 4 and FIGS. 5).
[0056] Specifically, based on Drawing 5, the first manifold is described as being distributed from biological culture reactors T1 to T6 to recovery centrifuges T1 to T2. The flow indicated by the solid line is the flow to centrifuge T1, and the flow indicated by the dotted line is the flow to centrifuge T2. At the contact points of each line, the flow of fluid can be blocked by a block valve, and each line can be individually CIP / SIP.
[0057] Likewise, a manifold of this type exists between the recovered cell culture harvesting solution vessels (HCCF vessels) and the purification trains, and through this manifold, free selection and distribution of trains is possible without cross-contamination between products and batches.
[0058]
[0059] In the present invention, “manifold” refers to a line bundle (equipment) in the form of a multi-channel structure in which multiple lines are compartmentalized by multiple valves to prevent cross-contamination, and which allows for the free selection and separation / distribution of subsequent recovery or purification trains. The line refers to a tube through which a culture medium or purified solution flows, and may be implemented through pipes or tubes, but is not limited thereto.
[0060] With this process design, the recombinant protein production system according to the present invention enables the free selection and distribution of culture medium and / or purified solution flows to each recovery train and purification train through a first manifold between the culture train and the recovery train and a second manifold between the recovery train and the purification train, thereby significantly improving process efficiency, such as process flexibility and minimization of PCO.
[0061]
[0062] In a production system according to one embodiment of the present invention, each purification train may share an outlet line of a bioreactor included in each culture train, and each purification train may be connected to a harvest train comprising one or more harvest units, and each purification train may share a harvest train with each bioreactor outlet line, but is not limited thereto.
[0063] In addition, in the production system according to the present invention, the culture medium containing recombinant protein in the outflow line or recovery unit of each bioreactor is transferred to a cell culture harvest fluid vessel (HCCF Vessel; Harvest Cell Culture Fluid Vessel) included in each recovery train, and the individual cell culture harvest fluid vessel and each purification train can be selectively transferred to a specific purification train through a valve installed in a connecting pipe, and the cell culture medium contained in one cell culture harvest fluid vessel may be in a form that can be split into two or more purification trains.
[0064]
[0065] In addition, in the multiple purification trains of the recombinant protein production system according to the present invention, each purification train is capable of independent, selective, and simultaneous operation, and is characterized by being capable of purifying and producing two or more products simultaneously without cross-contamination.
[0066] In particular, the multiple purification trains according to the present invention are characterized by being connected in series or in parallel. For example, as described in Fig. 1 or Fig. 2, two or more purification trains may be connected in parallel, and as described in Fig. 9, two or more purification trains connected in parallel may be connected in series.
[0067]
[0068] The meaning that the above purification trains are “atmospherically separated from one another” is that the air containing each purification train is not mixed with each other, preferably each purification train is located in a separate space (e.g., a room), and there is no mixing of air between the spaces where each purification train is located without an intersecting air flow, but is not limited thereto.
[0069] However, each refinement train may be connected by passing through an atmospherically separated buffer zone, and may be characterized in that they may be connected to each other through spaces such as corridors that each refinement train comes into contact with, for example, but are not limited thereto.
[0070]
[0071] The meaning that the fluid flow including the above-mentioned product and buffer is “mechanically segregated” is that the fluid flow of cell culture medium, medium and buffer, and purified solution, etc., in each culture train and purification train flows only within different pipes and tubes and is not mixed with one another, but is not limited thereto.
[0072]
[0073] In the production system according to the present invention, each purification unit included in each purification train is characterized by being in a form that can move independently between individual purification trains. As each purification unit can move between purification trains in this way, the overall flexibility of the purification system can be dramatically improved.
[0074] Although each refining train is atmospherically separated from one another, they can be connected to each other through the spaces they come into contact with, for example, by passing through a separate cross-contamination prevention buffer room with an atmospheric separation before entering the corridor, allowing logistics, equipment, and workers to move from one refining train to another.
[0075] This is important know-how that eliminates the need for resources x N, including raw materials, equipment, and workers, including consumables in the factory, and provides the advantage of simultaneously achieving productivity and efficiency in resource input.
[0076]
[0077] In addition, the purification train according to the present invention may further include a purification buffer zone. In the present invention, the “purification buffer zone” is included in the purification train and is a space that is physically and atmospherically separated and capable of cleaning and disinfecting so that personnel / logistics / equipment can be moved between each train without exchange contamination. Each personnel / logistics / equipment may be moved in the order of, for example, purification process zone - purification buffer zone - cleanroom corridor - purification buffer zone - purification process zone, and it is preferable that each zone be composed of a cleanroom.
[0078] In addition, the room containing the purification train according to the present invention may additionally include one or more rooms selected from a connecting room and a column packing room (see FIG. 2).
[0079]
[0080] In a production system according to the present invention, the purification unit is selected from the group comprising a filter unit and a chromatography unit, and
[0081] The above filtration unit may be selected from the group consisting of nanofiltration, ultrafiltration, diafiltration, and depth filtration, and
[0082] The above chromatography unit may be characterized by including one or more chromatography units selected from the group consisting of affinity chromatography, ion exchange chromatography, hydrophobic interaction chromatography, size exclusion chromatography, and multi-modal chromatography, but is not limited thereto.
[0083]
[0084] In addition, each purification unit included in the production system according to the present invention, particularly in the purification train, is characterized by each independently including a dedicated buffer hold vessel for each purification unit.
[0085] Preferably, N buffer storage vessels for N buffers used in the purification of a single batch of product may be installed to enable independent or cross-operation. Since buffer preparation vessels do not need to store buffers while the purification process is in progress, it may be necessary to install a number sufficient to accommodate a minimum batch interval (based on the number of days until the final stage of the next batch of stock solution) schedule, taking into account the buffer vessel utilization rate and the time required for preparing the next buffer.
[0086] In other words, instead of preparing the buffer immediately before using the current batch, the buffer can be prepared during the subsequent unit process of the previous batch, thereby shortening the process time required for batch manufacturing. When using dedicated buffer storage containers for each unit purification unit, as in the system according to the present invention, the next batch medium can be prepared during the process of the subsequent unit purification unit and sequentially stored in the buffer storage container after use. This allows for immediate use without any delay as the process progresses, thereby drastically reducing the process time caused by buffer manufacturing and storage. This improvement in the system eliminates bottlenecks caused by buffer preparation, such as buffer manufacturing, transfer, and waiting time for the next buffer manufacturing, when using multiple purification systems, thereby generating a groundbreaking effect that can double the batch production speed based on the entire facility by a factor of N.
[0087] In particular, by equipping each purification unit with an exclusive buffer storage vessel, process efficiency can be enhanced, thereby optimizing the PCO. This allows for immediate input into the process without the time required for buffer preparation, shortens the PCO associated with buffer preparation independent of process progress, reduces the number of buffer storage vessel turnovers (change over, CIP, SIP), and increases overall process efficiency by reducing process time and the number of buffer preparation vessels through the use of Prep-Multi Batch.
[0088] This is because chromatography units typically use four to five or more types of buffers, and since these buffers have a fixed hold time, process efficiency can be improved by preparing and storing the buffers in advance and using them when needed in the process.
[0089] However, in addition to its exclusive buffer storage vessel, each purification unit may include some buffer storage vessels shared with other purification units (such as purified water, pH adjustment buffers, etc.), and these same buffers may be contained in a buffer preparation vessel and supplied to each buffer storage vessel.
[0090] According to one embodiment of the present invention, the culture medium of each bioreactor included in a plurality of culture trains may be concentrated in a recovery train before being transferred to a purification train, and the concentration unit for concentrating the cell culture medium may be included in the recovery train and located between the culture train and the purification train, but is not limited thereto.
[0091] The above concentration unit is preferably a centrifugal or deep filtration unit, but it is obvious to a person skilled in the art that a conventional concentration unit may be used.
[0092] In a recombinant protein production system according to one embodiment of the present invention, each purification unit includes a product pool vessel for storing the purified product from each purification unit, and each product pool vessel may be characterized as having two or more, and each product pool vessel may be connected in series or in parallel, and the purified product may be transferred between each product pool vessel.
[0093]
[0094] In a recombinant protein production system according to one embodiment of the present invention, the recombinant protein may be one or more selected from the group consisting of antibodies, therapeutic proteins, enzymes, and hormones, but is not limited thereto, and the recombinant proteins produced in each of the bioreactors may be independently different or identical.
[0095] The above antibody should be understood as a concept that includes not only conventional monoclonal antibodies and their fragments, but also dual or multiple antibodies targeting two or more antigens, antibody-drug conjugates, etc.
[0096]
[0097] In addition, the present invention provides a method for producing a recombinant protein using a production system according to the present invention.
[0098] Specifically, after protein purification in a specific purification train is completed, the supply of culture medium to the specific purification train is stopped and the culture medium can be supplied to another purification train, and the specific purification train from which the supply of culture medium was stopped may be characterized by constructing a purification train for other protein purification and performing purification, but is not limited thereto.
[0099]
[0100] When using the production system according to the present invention, purification processes can be carried out simultaneously on the second or third purification train even while the purification process is in progress on the first purification train, thereby significantly increasing the annual production batch count, which was previously limited to one purification production period when using one purification production facility.
[0101] In particular, when producing high-titer products, dividing a single culture batch into N tablets to carry out the purification process enables product production without loss of the factory's annual production days or at a faster rate.
[0102] In addition, by using buffer storage vessels dedicated to each purification unit for each type of buffer, the increase in facilities due to the use of various buffer storage vessels can be minimized, and at the same time, the utilization rate can be maximized by minimizing the surplus waiting time of the buffer preparation (Prep) vessel, so the effect of reducing facilities due to the reduction in the number of buffer preparation vessels is also achieved.
[0103] It is possible to produce antibodies 1 and 2 simultaneously using multiple purification trains and to perform continuous batch polymerization (conjugation process) without freezing / thawing processes, thereby preventing loss of production time due to freezing (freeze) storage / thawing processes and the total production period of the final product (stock solution).
[0104]
[0105] Specifically, when producing multiple antibodies in a facility consisting of a conventional 1 culture train : 1 purification train, the following process can typically be expected.
[0106] Step 1: Preparation of polymerization (conjugation) antibody α batch followed by purification → Freeze Holding → PCO 1
[0107] Step 2: Purification after preparation of polymerization antibody b batch → Freeze Holding → PCO2
[0108] Purification process for 3-step polymerization → PCO3
[0109] In the case of a conventional recombinant protein production system in a facility consisting of one culture train and one purification train, there are problems such as the inability to produce continuous batches, loss of time due to PCO, increased production time due to the freeze storage process, and financial loss due to storage.
[0110] However, when applying a recombinant protein production system including multiple purification trains according to the present invention, continuous batch production is possible without loss of PCO 1 and PCO 2 periods within the same period, continuous batch production is possible in less than 1 / 3 of the period compared to conventional recombinant protein production systems, and a freeze storage process is unnecessary.
[0111]
[0112] In addition, in the case of the chromatography column purification process, when using a column of the same size (e.g., 0.8 m to 1.8 m), the purification process time increases proportionally to the total amount of harvested product (product amount, concentration g / L) due to the limitation of the resin's adsorption capacity (15 to 75 g / L) range.
[0113] For example, when performing a harvest process for 15,000 L of culture medium with a protein concentration of 2 g / L, if approximately 27,000 g of protein needs to be purified (Pro-A process) and a 1.4 m size column filled with resin of 34 g / L binding capacity is used, it takes 3 cycles (24 h). Then, to process a culture medium with a protein concentration of 9 g / L under the same conditions, the column must take 12 cycles (96 h) to process it.
[0114] However, if purification is performed using the multi-purification train system of the present invention, the corresponding column process (Pro-A) can be carried out in 48 h, which is half of this time.
[0115]
[0116] Furthermore, even when two batches are processed simultaneously, logistics, equipment, and workers can be moved between trains during the simultaneous processing of the preceding and subsequent batches, requiring only 1.1 to a maximum of 1.5 times the resources rather than 2 times the resource input. This is an example of a two-batch simultaneous process, and the number of batches that can be processed simultaneously and the effect of resource efficiency are not limited to this.
[0117]
[0118] By using the production system according to the present invention, purification processes can be carried out simultaneously in the second or third purification train even while the purification process is being carried out in the first purification train, thereby significantly increasing the number of annual production batches that were previously dependent on one purification production period when using one purification production facility. In particular, when producing high-titer products, one culture batch can be divided into N purifications to carry out the purification production process, thereby enabling product production without loss of the factory's annual production days or at a faster speed.
[0119] In addition, by using buffer storage vessels dedicated to each purification unit for each type of buffer, the increase in facilities due to the use of various buffer storage vessels can be minimized, and at the same time, the operating rate can be maximized by minimizing the surplus waiting time of buffer preparation vessels, thereby also having the effect of reducing facilities due to the reduction in the number of buffer preparation vessels.
[0120]
[0121] Figure 1 is a schematic diagram of a multi-refining train according to one embodiment of the present invention.
[0122] Figure 2 is a schematic diagram of a multi-refining train including a connecting room and a column packing room according to one embodiment of the present invention.
[0123] Figure 3 is a schematic diagram of a production system including a multi-culture train, a recovery train, and a purification train according to one embodiment of the present invention.
[0124] Figure 4 is a schematic diagram of a recovery train including a dual cell culture harvesting solution vessel (HCCF vessel: Harvest Cell Culture Fluid vessel) according to one embodiment of the present invention.
[0125] Figure 5 is a schematic diagram of a production system including a manifold according to one embodiment of the present invention.
[0126] Figure 6 is a schematic diagram of a system including a purification train and a buffer hold vessel for each unit process according to one embodiment of the present invention.
[0127] Figure 7 is a schematic diagram of an independent CIP configuration according to one embodiment of the present invention.
[0128] Drawing 8 is a schematic diagram of a system including a manifold according to one embodiment of the present invention.
[0129] Figure 9 is a schematic diagram of a recombinant protein production system for multiple antibody production according to one embodiment of the present invention.
[0130]
[0131] Specific details for implementing the invention
[0132] The present invention will be described in detail below with reference to examples.
[0133] To enable continuous refining of the same or different products within a single factory and to reduce production intervals between batches, it is necessary to configure the facility in a way that prevents cross-contamination between products and batches while ensuring efficient movement paths for the sharing of workers and utilities. In this invention, two main types of refining configurations are presented as examples.
[0134]
[0135] Example 1. A recombinant protein production system comprising a dedicated buffer hold vessel for each purification unit
[0136] Train configuration of the same design:
[0137] First, a dedicated buffer hold vessel is used for each purification unit included in the purification train within the production system according to the present invention.
[0138] To illustrate with an example of a system containing two bioreactors and two purification trains, filter units such as chromatography or UF / DF typically use four to five or more types of buffers in a single process, and these buffers have a fixed hold time. Therefore, it is important to prepare and store the buffers in advance so that they can be used when needed in the process.
[0139] Therefore, for each purification unit, buffers of each type may be contained in individual buffer storage containers as shown in Figure 1 or Figure 2 and transferred to each purification unit.
[0140] To this end, buffer preparation vessels and buffer hold vessels connected by piping are configured, and buffers can be transferred from these vessels to the process area and connected by piping to a transfer panel located in the process area, but are not limited thereto.
[0141] By configuring buffer storage containers according to buffer type in this way, a single preparation and storage can be used for multiple unit processes. For example, if Buffer A is used in the Column 1 process of Chromatography 1 and Buffer A is also used in the Column 3 process of Chromatography 3, the buffer can be prepared once, kept in a single hold vessel, and used for both Column 1 and Column 3 unit processes.
[0142] By configuring buffer storage containers according to buffer types, it is possible to use them for multiple batches with a single manufacturing and storage process. If buffer A is used in batch 1 and buffer A is used in batch 2, the buffer can be used for batch 1 and batch 2 with a single manufacturing and storage process.
[0143] In particular, since buffer holding vessels are used according to buffer type and each container uses only one type of buffer, the turnover time (switching time between products and semi-products) of the buffer holding vessels can be shortened by preparing and adding multiple buffers.
[0144] Also, in a preferred form, the room containing the purification train according to the present invention may additionally include one or more rooms selected from a connecting room and a column packing room (see FIG. 2).
[0145]
[0146] Example 2. Recombinant protein production system comprising multiple purification trains
[0147] Multiple purification trains in a recombinant protein production system according to one embodiment of the present invention are connected to at least one bioreactor for producing recombinant proteins.
[0148] As illustrated in Figures 3 and 4, each purification train may share the outlet line of each bioreactor within the culture train, and a harvest train comprising one or more harvest units may be located between the outlet line of each bioreactor and each purification train, and the outlet line of each bioreactor and each purification train may share the harvest train, but are not limited thereto.
[0149] Preferably, the culture medium containing the recombinant protein in the effluent line of the bioreactor or in each recovery unit is transferred to a Harvest Cell Culture Fluid Vessel (HCCF Vessel), and each individual Harvest Cell Culture Fluid Vessel and each purification train can be selectively transferred to a specific purification train through a valve installed in a connecting pipe, and the cell culture medium contained in one Harvest Cell Culture Fluid Vessel can be split into two or more purification trains.
[0150] Additionally, the culture medium of each bioreactor may be concentrated before being transferred to the purification train, and the concentration unit for concentrating the cell culture medium may be located between the recovery line and the purification train, and the concentration unit is preferably centrifuged or deep filtration, but is not limited thereto.
[0151]
[0152] In one configuration, it is desirable to install N multiples of buffer preparation vessels—that is, N buffer hold vessels for N buffers used to purify a batch of product—so that they can operate independently or in a cross-operation manner. Since buffer preparation vessels do not need to store buffers during the purification process, it is necessary to install a number sufficient to accommodate the minimum batch interval schedule (based on the number of days until the final stage of the next batch stock solution), taking into account the buffer vessel utilization rate and the time required to prepare the next buffer (refer to Figure 6 Buffer prep, Buffer hold vessel configuration).
[0153]
[0154] Example 3. Design of a plant including multiple refining trains
[0155] The method of configuring two purification trains allows for a configuration where the cleanroom is in the center and the machine room surrounds the cleanroom, or where the machine room is in the center and the cleanroom surrounds the machine room. Multiple purification train configurations are made possible by using a combination of the above forms, thereby enabling multiple purification train configurations that optimize the distribution of utilities and equipment and the movement of workers.
[0156]
[0157] Specifically, a method in which the cleanroom of a refining train of the same design is centralized and the machine room (Technical core) is externalized, or a method in which the machine room (Technical core) of a refining train of the same design is centralized and the cleanroom is externalized may be used.
[0158] Typically, in the design of a single purification train, equipment for cleaning in place (CIP) is generally shared across multiple facilities without separate distinction, but in the present invention, a CIP skid dependent on each purification train and each purification unit included therein can be configured for each unit process.
[0159] As a result, the productivity of the facility (total production volume during the same period) is improved by preventing cross-contamination caused by sharing cleaning lines between trains, completely independent operation unaffected by the process schedule of each train, and reducing product / batch changeover time.
[0160]
[0161] In addition, to improve the annual productivity of independent CIP skids, it is necessary for N purification trains to operate simultaneously. To this end, an independent CIP skid configuration is required for each train to operate independently for the purification process equipment (Column, UF / DF, Depth Filtration, Virus Filtration), Vessel, and line.
[0162] This independent CIP configuration is exemplified in Figure 7.
[0163]
[0164] Meanwhile, N refine trains
[0165] In order to operate it in one factory, the risk of cross-cantamination must be eliminated. To this end, the HVAC system among the utilities is configured to be separated for each purification train, thereby preventing cross-contamination through the air.
[0166] In order to obtain a production speed of up to N times through independent process operation, a Washing Room is installed and operated in the area containing the tablet unit within each tablet train, in which the COP (Clean Out of Place), GWD (Glass Washer & Dryer), and Autoclave, which are essential for process preparation, are installed sequentially according to the washing / sterilization flow.
[0167] If a campaign requiring the simultaneous use of all purification trains must be executed continuously, a separate column packing space (off-line column packing room) can be included per train to reduce the product changeover period associated with resin packing / unpacking of the column to zero.
[0168]
[0169] Example 4. Simultaneous production / purification system for two or more products using multiple purification trains
[0170] A multi-pipeline system that connects N bioreactors into N purification trains is called a manifold. In the manifold, the Bioreactor → Harvest → Purification (DSP) Train can be selected independently, with Train 1 flowing upwards and Train N flowing downwards.
[0171] Based on this, it is possible to simultaneously produce antibody 1 and antibody 2 using multiple purification trains and to produce continuous batch polymerization (conjugation process) without freezing / thawing processes, thereby preventing loss of production time due to freezing (freeze) storage / thawing processes and the total production period of the final product (stock solution).
[0172] That is, as shown in Figure 8, it can be operated in a manifold form where the bioreactor → harvest → purification (DSP) train can be selected independently.
[0173]
[0174] Example 5. Dual-antibody production system
[0175] By using the production system according to the present invention, the productivity problem, which was the biggest bottleneck in conventional multi-antibody production, can be resolved without the freezing / thawing process of semi-finished products (mono-antibody), costs associated with storage containers and storage during freezing, process waiting time, and loss of production days due to product changeover.
[0176] As described in FIG. 9, for example, two purification trains capable of purifying product A for one arm of the bispecific antibody and product B for the other arm of the bispecific antibody are positioned in parallel, and then two purification trains connected in series are connected to split product A 1 / 2 and product B 1 / 2 each into their respective purification trains to form heterodimers and purify them, thereby allowing for the efficient production of bispecific antibodies or multiple antibodies.
[0177]
[0178] The present invention has been described above with reference to examples, but it is obvious to a person skilled in the art that the scope of the present invention is not limited to the examples and extends to the scope of equivalents.
Claims
1. Multiple culture trains comprising at least one bioreactor for producing recombinant proteins; A plurality of recovery trains comprising at least one recovery unit for recovering the produced recombinant protein from the bioreactor; and A recombinant protein production system comprising multiple purification trains, each comprising at least one purification unit for purifying the recombinant protein produced above, The above multiple culture trains and the above multiple recovery trains are connected through a first manifold, and A recombinant protein production system in which the above multiple recovery trains and the above multiple purification trains are connected through a second manifold.
2. In Paragraph 1, A recombinant protein production system characterized by the above multiple purification trains being atmospherically separated from each other.
3. In Paragraph 1, A recombinant protein production system characterized in that each of the purification units independently includes a dedicated buffer storage container for each purification unit.
4. In Paragraph 1, The above multiple purification train is a recombinant protein production system that further includes a purification buffer zone.
5. In Paragraph 2, A recombinant protein production system characterized in that the above multiple purification trains can be connected to each other in the space in contact with each purification train.
6. In Paragraph 1, A recombinant protein production system characterized in that the purification unit is each independently selected from the group consisting of a filter unit and a chromatography unit.
7. In Paragraph 6, A recombinant protein production system characterized in that the above filtration unit is each independently selected from the group consisting of nanofiltration, ultrafiltration, diafiltration, and depth filtration.
8. In Paragraph 6, A recombinant protein production system characterized in that each of the above chromatography units is independently one or more selected from the group consisting of affinity chromatography, ion exchange chromatography, hydrophobic interaction chromatography, size exclusion chromatography, and multi-modal chromatography.
9. In Paragraph 6, A recombinant protein production system characterized in that the purification units are each in a form that allows for independent movement between individual purification trains.
10. In Paragraph 1, A recombinant protein production system characterized in that the multiple purification trains each independently share the effluent line of the bioreactor.
11. In Paragraph 10, The above recovery train includes a cell culture harvesting solution container, and A recombinant protein production system characterized in that a culture medium containing recombinant protein in the effluent line of each bioreactor or in each recovery unit is transferred to the cell culture harvest solution container, and individual cell culture harvest solution containers and each purification train can be selectively transferred to a specific purification train through a valve installed in a connecting pipe.
12. In Paragraph 11, A recombinant protein production system in which each of the above recovery trains independently comprises two or more cell culture harvesting solution containers.
13. In Paragraph 12, A purification system characterized in that the cell culture medium contained in the cell culture harvesting solution container is in a form that can be independently distributed into two or more purification trains.
14. In Paragraph 10, A recombinant protein production system characterized in that the culture medium of each bioreactor is concentrated before being transferred to a purification train.
15. In Paragraph 14, A recombinant protein production system characterized in that a concentration unit for concentrating the cell culture medium is located within a recovery train.
16. In Paragraph 15, A recombinant protein production system characterized in that the above concentration unit is centrifugation or deep filtration.
17. In Paragraph 1, A recombinant protein production system characterized in that each purification unit includes a product pool container for storing purified products from each purification unit, and each product pool container has two or more.
18. In Paragraph 17, A recombinant protein production system characterized in that each product pool container is connected in series or in parallel, and purified products can be transferred between each product pool container.
19. In Paragraph 1, A recombinant protein production system characterized in that the recombinant protein is one or more selected from the group consisting of antibodies, therapeutic proteins, enzymes, and hormones.
20. In Paragraph 1, A recombinant protein production system characterized in that the above-mentioned recombinant protein is a double antibody.
21. In Paragraph 1, A recombinant protein production system characterized in that the recombinant proteins produced in each of the above bioreactors are independently different or identical.
22. A method for producing a recombinant protein using a recombinant protein production system according to any one of claims 1 to 21, A method for producing a recombinant protein, characterized in that after protein purification in a specific purification train is completed, the supply of culture medium to said specific purification train is stopped and the culture medium can be supplied to another purification train, and then the specific purification train from which the supply of culture medium was stopped performs the construction of a purification train for another protein purification.
